Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL6141 Target Snapshot

Acyl-CoA:cholesterol acyltransferase · SINGLE PROTEIN · Oryctolagus cuniculus

929Compounds
77Assays
1Approved Drugs
1,086.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt Q95214. Use UniProt Q95214 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q95214 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Acyl-CoA:cholesterol acyltransferase as ChEMBL target CHEMBL6141, mapped to UniProt Q95214. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Acyl-CoA:cholesterol acyltransferase
SINGLE PROTEIN · Oryctolagus cuniculus
As of 2026-09-14
ChEMBL target ID
CHEMBL6141
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
Q95214
Sterol O-acyltransferase 1
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Acyl-CoA:cholesterol acyltransferase is the right protein anchor across sources, using UniProt Q95214 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelSterol O-acyltransferase 1
UniProt AccessionQ95214
Component TypeProtein
Sequence Length305 aa

Sterol O-acyltransferase 1

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Acyl-CoA:cholesterol acyltransferase, mapped to UniProt Q95214. ChEMBL maps the protein component as Sterol O-acyltransferase 1. Sequence length is 305 aa.

Mapped IDQ95214
Review nameAcyl-CoA:cholesterol acyltransferase
OrganismOryctolagus cuniculus
Clinical Profile

Clinical Phase Distribution

1
Approved
4
Phase II
Assay Mix

Activity Type Distribution

IC501,086.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL160103 8.4 IC50 4.0 Preclinical
CHEMBL164479 8.4 IC50 4.0 Preclinical
CHEMBL102026 8.22 IC50 6.0 Preclinical
CHEMBL422709 8.22 IC50 6.0 Preclinical
CHEMBL64237 8.22 IC50 6.0 Preclinical
CHEMBL101096 8.15 IC50 7.0 Preclinical
CHEMBL322919 8.15 IC50 7.0 Preclinical
CHEMBL353791 8.15 IC50 7.0 Preclinical
CHEMBL40608 8.15 IC50 7.0 Preclinical
CHEMBL309560 8.1 IC50 8.0 Preclinical
Distribution

pChEMBL Value Distribution

64
5.0
72
5.5
154
6.0
219
6.5
274
7.0
171
7.5
19
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

77
Total Assays
935
Tested Compounds
2
Assay Types
Binding — 67 assays, 935 compounds
BAO Format Assays Compounds Avg pChEMBL
microsome format 23 371 6.9
assay format 21 355 6.7
single protein format 14 40 7.2
tissue-based format 9 169 6.6
Functional — 10 assays, 23 compounds
BAO Format Assays Compounds Avg pChEMBL
organism-based format 5 0
microsome format 2 22 7.0
tissue-based format 2 0
assay format 1 1 7.6

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine